↓ Skip to main content

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

Overview of attention for article published in Cochrane database of systematic reviews, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
29 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
Published in
Cochrane database of systematic reviews, November 2018
DOI 10.1002/14651858.cd008170.pub3
Pubmed ID
Authors

Yu Jie Chen, Liang Jin Li, Wen Lu Tang, Jia Yang Song, Ru Qiu, Qian Li, Hao Xue, James M Wright

Twitter Demographics

The data shown below were collected from the profiles of 29 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 60 98%

Demographic breakdown

Readers by professional status Count As %
Unspecified 15 25%
Student > Bachelor 10 16%
Student > Doctoral Student 7 11%
Student > Ph. D. Student 7 11%
Student > Master 6 10%
Other 16 26%
Readers by discipline Count As %
Medicine and Dentistry 25 41%
Unspecified 18 30%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Nursing and Health Professions 4 7%
Computer Science 3 5%
Other 7 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2019.
All research outputs
#888,273
of 12,808,036 outputs
Outputs from Cochrane database of systematic reviews
#2,889
of 10,430 outputs
Outputs of similar age
#37,168
of 293,250 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 56 outputs
Altmetric has tracked 12,808,036 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,430 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.4. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,250 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.